These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12939463)

  • 1. Combination treatment with 1alpha,25-dihydroxyvitamin D3 and 9-cis-retinoic acid directly inhibits human telomerase reverse transcriptase transcription in prostate cancer cells.
    Ikeda N; Uemura H; Ishiguro H; Hori M; Hosaka M; Kyo S; Miyamoto K; Takeda E; Kubota Y
    Mol Cancer Ther; 2003 Aug; 2(8):739-46. PubMed ID: 12939463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1.
    Blutt SE; Allegretto EA; Pike JW; Weigel NL
    Endocrinology; 1997 Apr; 138(4):1491-7. PubMed ID: 9075707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase.
    Jiang F; Bao J; Li P; Nicosia SV; Bai W
    J Biol Chem; 2004 Dec; 279(51):53213-21. PubMed ID: 15485861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of renal parathyroid hormone receptor expression by 1, 25-dihydroxyvitamin D3 and retinoic acid.
    Sneddon WB; Barry EL; Coutermarsh BA; Gesek FA; Liu F; Friedman PA
    Cell Physiol Biochem; 1998; 8(5):261-77. PubMed ID: 9792954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA.
    Kahlen JP; Carlberg C
    Nucleic Acids Res; 1997 Nov; 25(21):4307-13. PubMed ID: 9336462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 9-cis-Retinoic acid represses transcription of the gonadotropin-releasing hormone (GnRH) gene via proximal promoter region that is distinct from all-trans-retinoic acid response element.
    Cho S; Chung J; Han J; Ju Lee B; Han Kim D; Rhee K; Kim K
    Brain Res Mol Brain Res; 2001 Mar; 87(2):214-22. PubMed ID: 11245924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by retinoic acids.
    Choi SH; Kang HK; Im EO; Kim YJ; Bae YT; Choi YH; Lee KH; Chung HY; Chang HK; Kim ND
    Int J Oncol; 2000 Nov; 17(5):971-6. PubMed ID: 11029500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoic acid receptor alpha and retinoid-X receptor-specific agonists synergistically target telomerase expression and induce tumor cell death.
    Pendino F; Dudognon C; Delhommeau F; Sahraoui T; Flexor M; Bennaceur-Griscelli A; Lanotte M; Ségal-Bendirdjian E
    Oncogene; 2003 Dec; 22(57):9142-50. PubMed ID: 14668795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel human cell culture model for the study of familial prostate cancer.
    Yasunaga Y; Nakamura K; Ewing CM; Isaacs WB; Hukku B; Rhim JS
    Cancer Res; 2001 Aug; 61(16):5969-73. PubMed ID: 11507036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo regulation of hTERT expression and telomerase activity by androgen.
    Guo C; Armbruster BN; Price DT; Counter CM
    J Urol; 2003 Aug; 170(2 Pt 1):615-8. PubMed ID: 12853842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo.
    Kang S; Li XY; Duell EA; Voorhees JJ
    J Invest Dermatol; 1997 Apr; 108(4):513-8. PubMed ID: 9077483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel human cancer culture model for the study of prostate cancer.
    Yasunaga Y; Nakamura K; Ko D; Srivastava S; Moul JW; Sesterhenn IA; McLeod DG; Rhim JS
    Oncogene; 2001 Nov; 20(55):8036-41. PubMed ID: 11753687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S; Kyo S; Banerjee PP
    Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The anti-proliferative effect of vitamin D3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity.
    Nayeri S; Danielsson C; Kahlen JP; Schräder M; Mathiasen IS; Binderup L; Carlberg C
    Oncogene; 1995 Nov; 11(9):1853-8. PubMed ID: 7478614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
    Ouchi H; Ishiguro H; Ikeda N; Hori M; Kubota Y; Uemura H
    Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of vitamin D3 on keratinocyte proliferation and differentiation in vitro: modulation by ligands for retinoic acid and retinoid X receptors.
    Sørensen S; Sølvsten H; Politi Y; Kragballe K
    Skin Pharmacol; 1997; 10(3):144-52. PubMed ID: 9287395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid X receptor-specific ligands synergistically upregulate 1, 25-dihydroxyvitamin D3-dependent transcription in epidermal keratinocytes in vitro and in vivo.
    Li XY; Xiao JH; Feng X; Qin L; Voorhees JJ
    J Invest Dermatol; 1997 Apr; 108(4):506-12. PubMed ID: 9077482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans and 9-cis retinoic acid enhance 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells.
    Nakajima H; Kizaki M; Ueno H; Muto A; Takayama N; Matsushita H; Sonoda A; Ikeda Y
    Leuk Res; 1996 Aug; 20(8):665-76. PubMed ID: 8913320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma.
    Kunisada M; Budiyanto A; Bito T; Nishigori C; Ueda M
    Br J Dermatol; 2005 Mar; 152(3):435-43. PubMed ID: 15787811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
    He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
    Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.